Stay updated on ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial

Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Comparison shows only minor formatting/layout updates and a revised last-updated timestamp on the Study Details page, with no changes to core study content, eligibility criteria, outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T20:51:16.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources; - Updated software version from v3.1.0 to v3.2.0; - Removed the old version reference.
    Difference
    3%
    Check dated 2025-10-06T05:23:36.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Updated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.
    Difference
    0.4%
    Check dated 2025-09-29T03:03:17.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.0.2 added; previous v3.0.1 removed, and the 'Back to Top' element was deleted.
    Difference
    0.2%
    Check dated 2025-09-14T18:58:30.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T14:23:50.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and specific locations for drug availability, as well as the introduction of new drug safety and information sections. Notably, the drug efgartigimod alfa is now highlighted.
    Difference
    8%
    Check dated 2025-08-31T11:43:23.000Z thumbnail image

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.